logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11576891 B1

PDFFull Text
Date of Patent:
Feb. 14, 2023

Filed:

Jun. 16, 2011

Methods of treating or preventing estrogen-related diseases

Applicant:

Fernand Labrie, Québec, CA;

Inventor:

Fernand Labrie, Québec, CA;

Assignee:

ENDORECHERCHE, INC.;

Attorney:

Ostrolenk Faber LLP

Primary Examiner:

Kara R McMillian

Int. Cl.
CPC ...
A61K 31/35 (2006.01); A61K 31/56 (2006.01); A61K 31/453 (2006.01); A61K 45/06 (2006.01); A61P 5/04 (2006.01); A61P 5/24 (2006.01); A61P 5/30 (2006.01); A61P 15/08 (2006.01); A61P 15/00 (2006.01); A61P 15/02 (2006.01); A61P 25/28 (2006.01); A61P 25/06 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/35 (2013.01); A61K 31/453 (2013.01); A61K 31/56 (2013.01); A61K 45/06 (2013.01); A61P 5/04 (2018.01); A61P 5/24 (2018.01); A61P 5/30 (2018.01); A61P 15/00 (2018.01); A61P 15/02 (2018.01); A61P 15/08 (2018.01); A61P 25/06 (2018.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01);
Abstract

Methods for treating or reducing the likelihood of acquiring estrogen-related (e.g. estrogen-exacerbated) diseases including endometriosis include administering to a patient a selective estrogen receptor modulator (SERM), in combination with inhibiting ovarian secretions, e.g., by administering an LHRH agonist or antagonist. In some embodiments, a precursor of sex steroids, said precursor being selected from the group consisting of dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), androst-5-ene-3β,17β-diol (5 diol), and androstenedione or a compound transformed into one of these, is also administered.

Find Patent Forward Citations

Labrie, Fernand. (2023). Methods of treating or preventing estrogen-related diseases (U.S. Patent No. 11576891). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11576891

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…